A detailed history of Ameriflex Group, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Ameriflex Group, Inc. holds 1,512 shares of MRNA stock, worth $40,158. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,512
Previous 1,712 11.68%
Holding current value
$40,158
Previous $67.5 Million 36.48%
% of portfolio
0.02%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

SELL
$28.35 - $47.53 $5,670 - $9,506
-200 Reduced 11.68%
1,512 $42.9 Million
Q4 2024

Feb 24, 2025

BUY
$36.85 - $63.93 $63,087 - $109,448
1,712 New
1,712 $67.5 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $10.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Ameriflex Group, Inc. Portfolio

Follow Ameriflex Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriflex Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameriflex Group, Inc. with notifications on news.